Skip to main content
. 2019 Jun 28;10:2892. doi: 10.1038/s41467-019-10769-x

Table 1.

Publicly available human data sets used in this paper

Data set ID Total Responders Nonresponders Ref.
Infliximab:
  GSE12251 23 11 12 13
  GSE73661 23 15 8 15
  GSE23597 32 7 25 14
  GSE16879 24 16 8 12
  Sum 102 49 53
Vedolizumab:
  GSE73661 37 23 14 15
Pediatric UC:
  GSE109142 206 105 101 33

Data sets used for the classification of ulcerative colitis molecular profiles. Only the number of patients used for analysis are shown (inflamed mucosa before receiving any therapy)